An announcement from Cann Group Ltd. ( (AU:CAN) ) is now available.
Cann Group Ltd. has announced the issuance of 10,026,950 fully paid ordinary shares as part of their new securities quotation application. This move is significant for Cann Group as it could enhance their capital base and facilitate further investment in their operations, potentially strengthening their position in the medicinal cannabis sector.
More about Cann Group Ltd.
Cann Group Ltd. operates in the pharmaceutical and biotechnology industry, focusing on the cultivation and production of medicinal cannabis. The company targets the growing market for cannabis-based therapeutics and wellness products.
YTD Price Performance: 209.09%
Average Trading Volume: 1,516
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $10.82M
Find detailed analytics on CAN stock on TipRanks’ Stock Analysis page.